Wedge Capital Management’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-119,447	Closed	-$1.8M	–	525
2024 Q3	$1.8M	Buy	119,447 +67,947	+132%	+$1.02M	0.03%	344
2024 Q2	$1.47M	Sell	51,500 -4,883	-9%	-$140K	0.03%	349
2024 Q1	$1.65M	Buy	56,383 +24,969	+79%	+$730K	0.03%	346
2023 Q4	$1.06M	Buy	+31,414	New	+$1.06M	0.02%	355